Form 4: Cryo-Cell Co-CEO Portnoy Boosts Stock Holdings

Cryo-Cell International's Chairman and Co-CEO, David Portnoy, reported recent acquisitions of common stock, increasing his beneficial ownership.

Summary

• David Portnoy, Chairman and Co-CEO of Cryo-Cell International Inc. (CCEL), acquired additional common stock on November 20 and 21, 2025.
• On November 20, 2025, he acquired 289 shares at $4.00 per share.
• On November 21, 2025, he acquired 800 shares at $4.04 per share.
• Additionally, on November 21, 2025, he acquired 677 shares at $4.09, 406 shares at $4.09, and 273 shares at $4.10, all as Custodian for his son.
• Following these transactions, his direct beneficial ownership of common stock is 847,629 shares.
• His indirect beneficial ownership totals 853,859 shares, held through various entities and as custodian for his son.
• Portnoy also holds 530,000 stock options with exercise prices ranging from $4.30 to $12.27, and various vesting and expiration dates extending to 2030.

Sentiment

Score: 8

Explanation: The Chairman and Co-CEO's acquisition of additional common stock suggests strong confidence in the company's valuation and future performance.

Positives

• Chairman and Co-CEO David Portnoy increased his direct beneficial ownership of common stock by 1,089 shares through open market purchases.
• The purchases were made at prices ranging from $4.00 to $4.04 for direct shares, indicating management's confidence at these price levels.
• Additional shares were acquired indirectly as custodian for his son at prices up to $4.10, further demonstrating commitment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Shares of Common Stock held by PartnerCommunity, Inc., where David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
• Shares of common stock held by uTIPu, Inc., where David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
• Shares of common stock held by Mayim Limited Partnership, where David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
• Shares held as Custodian for son.
• Shares held by Spouse.

Stakeholder Impact

• Shareholders: Increased confidence due to significant insider buying, suggesting strong belief in the company's future value by top management.
• Investment Professionals: Provides a positive signal regarding management's perspective on the company's stock valuation.

Next Steps

• Vesting of 1/3 of 50,000 stock options on December 22, 2025 (from 12/22/2023 grant).
• Vesting of 11,501 stock options on January 2, 2026 (from 01/03/2023 grant).
• Vesting of 1/3 of 50,000 stock options on January 21, 2026 (from 01/21/2025 grant).
• Vesting of 1/3 of 50,000 stock options on January 21, 2027 (from 01/21/2025 grant).
• Potential immediate vesting of 280,000 stock options if the Company's common stock reaches $25.00 per share during the seven-year option term.

Key Dates

Recommendation

The Chairman and Co-CEO, a significant insider and 10% owner, has increased his direct and indirect holdings of common stock through open market purchases. This strong insider buying activity, particularly from a top executive, signals a high level of confidence in the company's current valuation and future prospects, making it a compelling 'buy' signal for investors.

Keywords

CRYO CELL INTERNATIONAL, CCEL, Form 4, insider trading, stock acquisition, beneficial ownership, stock options, David Portnoy